In vivo pharmacology of the new angiotensin II receptor antagonist KRH-594

被引：0
|
作者：
Murakami, M
Inada, Y
Tazawa, S
Wang, JX
Nakao, K
机构：
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P3842
引用
收藏
页码：R275 / R275
页数：1
相关论文
共 50 条
  • [31] Protein binding in plasma of valsartan, a new angiotensin II receptor antagonist
    Colussi, DM
    Parisot, C
    Rossolino, ML
    Brunner, LA
    Lefevre, GY
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (03): : 214 - 221
  • [32] Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension
    Baker, William L.
    White, William B.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1506 - 1515
  • [33] The new angiotensin II receptor antagonist, irbesartan - Pharmacokinetic and pharmacodynamic considerations
    Brunner, HR
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (12) : 311S - 317S
  • [34] The comparative pharmacology of angiotensin II receptor antagonists
    Burnier, M
    Maillard, M
    BLOOD PRESSURE, 2001, 10 : 6 - 11
  • [35] INVIVO PHARMACOLOGY OF L-158,809, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    SIEGL, PKS
    CHANG, RSL
    MANTLO, NB
    CHAKRAVARTY, PK
    ONDEYKA, DL
    GREENLEE, WJ
    PATCHETT, AA
    SWEET, CS
    LOTTI, VJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 139 - 144
  • [36] Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure
    Quan, Hailian
    Oh, Gyu Chul
    Seok, Seung Hyeok
    Lee, Hae-Young
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1400 - +
  • [37] IN-VIVO PHARMACOLOGY AND ANTIHYPERTENSIVE ACTIVITY OF L-159,282 (MK-996) A NONPEPTIDE ANGIOTENSIN-II (A-II) RECEPTOR ANTAGONIST
    SIEGL, PKS
    GABEL, RA
    ZINGARO, GJ
    SCHORN, T
    HARVEY, C
    ARBEGAST, P
    BROTEN, TP
    SCHAFFER, LW
    CHAKRAVARTY, PK
    GREENLEE, W
    NAVLOR, E
    PATCHETT, AA
    KIVLIGHN, SD
    FASEB JOURNAL, 1994, 8 (05): : A881 - A881
  • [38] FIMASARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, AMELIORATES AN IN VIVO ZEBRAFISH MODEL OF HEART FAILURE
    Oh, G. C.
    Lee, H. Y.
    Quan, H.
    Seok, S. H.
    JOURNAL OF HYPERTENSION, 2019, 37 : E202 - E202
  • [39] Antiproteinuric effect of angiotensin II receptor antagonist
    Kajioka, T
    Ueno, M
    Tsuchihashi, T
    Tominaga, M
    Goto, K
    JOURNAL OF HYPERTENSION, 2002, 20 : S366 - S366
  • [40] Orally active angiotensin II receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (11) : 489 - 489
12345